Both options are backed by Nooms behavior change tools and clinical care teamsso you get the guidance you need, no matter your path
Each box contains 25 vials of the product
Tirzepatide is administered as a once-weekly subcutaneous injection, with dosing typically initiated at 2.5 mg and gradually titrated upward (5 mg, 7.5 mg, 10 mg, 12.5 mg, to a maximum of 15 mg) based on therapeutic response and tolerability
It extends them into a preventive model
Enriched with Papaya Extract and gentle exfoliating acids, it washes away dirt, oil, and impurities while helping to smooth skin texture
GLP-1 receptor agonist labeling and safety information